news.cision.com

Investments in growth brings Biotage’s annual sales past the billion SEK milestoneFourth quarter October - December 2019 ·Net sales amounted to 288.6 MSEK (234.6), an increase by 23.0 percent compared to the corresponding quarter last year. At comparable exchange rates and adjusted for acquisitions[1)] sales increased by 8.7 percent. ·Operating profit increased by 5.9 percent to 37.9 MSEK (35.7). ·Result after tax amounted to 18.5 MSEK (27.3). ·Earnings per share amounted to 0.28 SEK (0.42) before and after dilution. ·The cash flow from operating

XMReality AB (publ), Year-end Report 2019

Order intake and billing in 2019 for software-as-a-service subscriptions (SaaS), which are now the company’s dominant source of revenue, increased by 86 percent and correspond to 96 (70) percent of XM Reality’s total order intake and billing. The gross margin rose to 93 (82) percent for the full year and 95 (83) percent in the fourth quarter. The company now has XMReality Remote Guidance subscription agreements with 55 customers.The quarter: October–December 2019 · Net sales amounted to SEK 3,222 thousand (3,250). · Costs totaled SEK -12,374 thousand (-13,124). · The operating

Year-end report 1 January – 31 December 2019

Performance for the quarter was at a historically high level and we note positive signals from our efforts to restore profitability during 2020.FOURTH QUARTER AND 1 JANUARY – 31 DECEMBER 2019 2019 2019 2018 2019 2019 2018(SEK million) Oct Oct Oct Jan Jan Jan– -Dec -Dec -Dec -Dec -Dec -Dec IFRS IAS IAS IFRS IAS IAS 16 17 17 16 17 17Net

Year-End Report 2019

ChromoGenics increases its business volume and completes preferential share issue for SEK 100.6 million, guaranteed to 75 percent, for accelerated growthFourth quarter of 2019 · Net sales for the period amounted to SEK 8.1 (6.8) million and earnings to SEK -23.2 (-22.9) million, which corresponds to earnings per share of SEK -0.06 (-0.53). Deliveries of backlogged customer orders for dynamic products were delayed during the quarter, which has meant that net sales have been postponed. · Gross profit amounted to SEK -6.5 million, which is a decrease of SEK -1.6 million compared to the

INVISIO announces its Year End Bulletin 2019 on February 13 at 14:00 CET followed by a conference call February 14 at 09:00 CET

INVISIO is pleased to invite press, investors and analysts to a conference call on February 14 at 09.00 CET where CEO Lars Højgård Hansen presents the Year End Bulletin 2019.The conference call, which will be held in English, will begin with a presentation ofthe Year End Bulletin followed by a Q&A session.The Year End Bulletin will be announced on February 13, 2020, at 14:00 CET.Phone number for the conference:To participate in the conference call, use the dial-in numbers below. Please dial in5-10 minutes prior to the scheduled start time in order to facilitate a timely start.

Indutrade acquires Finnish valve manufacturing company Jouka

Indutrade has on 6 February signed an agreement to acquire all of the shares in Jouka OY, with annual sales of approximately EUR 6.5 million. The agreement was signed after the market closed.Jouka designs and manufacturers ball valves and integrated ball valve solutions with a high degree of customisation. The company offers bespoke products with customer specific R&D. Customer segments include machine building, marine, process and pulp & paper industries primarily in the Finnish market. With high manufacturing flexibility, Jouka offers competitive delivery times

Year-end report Rejlers AB January – December 2019

October - December · Net sales increased by 17.5% to SEK 756.8 million (644.2) · Organic sales growth excluding exchange rate fluctuations amounted to 8.4% (-6.5) · EBITA increased to SEK 40.4 million (35.4) including impact from IFRS 16 Leases of SEK 2.2 million and the EBITA margin increased to 5.4% (5.5) · A three-day strike in Finland negatively impacted EBITA by SEK 4.2 million · Operating profit (EBIT) amounted to SEK 23.3 million (31.8) and the operating margin was 3.1 per cent (5.0) · EBIT was impacted by acquisition expenses of SEK 10.2 million · Profit after

Klaria receives 6.4 MSEK milestone payment from EU’s Horizon 2020 program to take Sumatriptan Alginate Film to market

Fri, Feb 07, 2020 08:25 CET

Today, Klaria Pharma Holding AB (publ) announces that the company has received a milestone payment of 6.4 MSEK from the EU’s Horizon 2020 program. The payment is made as the development of Sumatriptan Alginate film (KL-00119) continues to proceed successfully according to plan. Large-scale production of the product is on-going, and all preparations for the upcoming bioequivalence study are completed. This pivotal clinical study required for submission of approval is planned to start in the first half of 2020 with completion in 2020.The milestone payment of 6.4 MSEK is expected to cover

ChromoGenics conducts rights emission for SEK 100.6 million

The Board of Directors of ChromoGenics AB (”ChromoGenics” or ”the Company”) has today, pursuant to the authorization granted by the extraordinary general meeting on December 18, 2019, decided to conduct a new share issue of approximately SEK 100.6 million with preferential rights for existing shareholders (”the Rights Issue”). The Rights Issue is intended to finance the Company’s ongoing market establishment of ConverLight®, investments and loan-related payments. The Rights Issue is guaranteed at 75 percent through subscription and guarantee undertakings.Summary · The Board of

Loxam has placed their first Ironhand orders

Fri, Feb 07, 2020 08:20 CET

Loxam has placed orders for their first 82 Ironhand® systems at an order value of MSEK 5,6. The systems will be available for rental in 15 cities across France, fulfilling the demand for increased safety of workers across the country.Loxam and Bioservo signed an exclusive agreement in December 2019, an agreement that allows Loxam to offer Ironhand for rental all over France. Now the first orders of 82 Ironhand systems, including consumables and accessories, have been placed with a planned delivery schedule in batches during the spring. “Rental has proved to be an excellent way to try out

SAGAX PROPOSES DISTRIBUTION IN KIND OF SHARES IN TORSLANDA PROPERTY INVESTMENT TO SHAREHOLDERS

The Board of Directors of Sagax (publ) (“Sagax”) intends to propose a distribution in kind of shares in which 30 Class A or Class B common shares in Sagax will confer the right to one (1) share in Torslanda Property Investment AB (publ) (“TPI”) following a 10:1 split of the TPI share. The proportion of distributed shares corresponds to 15% of the number of shares in TPI. The Board intends to present the proposal to shareholders at Sagax’s Annual General Meeting on 6 May 2020. Sagax owns 78% of the number of outstanding shares and votes in TPI through Söderport Holding AB, which is

Invitation to Q4 Earnings Teleconference

Karnov Group (Nasdaq: KAR) will publish its financial report for the fourth quarter and fiscal year 2019 on February 21 at around 8.00 CET and Management will host a webcasted telephone conference the same day at 9.00 a.m. CET.Karnov Group’s year-end report for the period January – December 2019 will be published on Friday February 21, 2020 at around 8.00 a.m. CET. A webcasted telephone conference will be held at 9.00 a.m. the same day, where CEO Flemming Breinholt and CFO Dora Brink Clausen will present the report and answer questions. You can follow the presentation via webcast and ask

Nyfosa intends to propose dividend in kind of shares in Torslanda Property Investment AB

The Board of Directors of Nyfosa AB intends to propose the Annual General Meeting of Nyfosa to resolve on a dividend in kind in the form of shares corresponding to 15 percent of the total number of shares in Torslanda Property Investment AB ("TPI"). Nyfosa's joint venture Söderport Holding AB ("Söderport") currently owns 78 percent of TPI. Söderport is owned equally by Nyfosa and AB Sagax. TPI is a Swedish real estate company that owns and manages properties with a leasable area of 194,000 square meters and with a market value of SEK 3 billion. The company’s share is listed on Nasdaq

Recipharm has announced that Consort Medical will apply for delisting

Fri, Feb 07, 2020 08:10 CET

At 6.00 p.m. on 6 February 2020, Recipharm announced that it controlled approximately 75.9 per cent. of the existing issued share capital of Consort Medical plc (“Consort”). As Recipharm now controls over 75 per cent. of the share capital, Consort will apply for delisting from the London Stock Exchange and cancellation is expected to take effect from 6 March 2020. Following the delisting, Consort will be re-registered as a private company. About RecipharmRecipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry

OptiFreeze starts new business for the forest industry.

OptiFreeze has today signed an agreement with BCC, a leading company in the forest industry. The companies will together investigate the possibility to apply the OptiFreeze technology on forest plants.As a part of our business development we have analyzed the market for possible new areas in using our technology. We have found that parts of the forest industry are using cuttings for propagation. We already know that our technology works on cuttings and we see this as an interesting business opportunity. Approximately 8 billion cuttings are produced yearly, and a problem is weak survival for

Gunnebo Interim Report October-December 2019

Fri, Feb 07, 2020 08:01 CET

Steady Underlying Improvements During a Year of ChangePresident and CEO Stefan Syrén Comments: We have now left 2019 behind, which was an eventful year for Gunnebo. The Business Unit structure was finalised, and our regional organisations were phased out. I also communicated the implementation of a smaller, more focused management team. The feedback from our customers on the new organisation has been positive, and employee surveys show increased engagement from our employees. We closed the acquisition of Cominfo and integrated the business into Entrance Control, launched a cost efficiency

Africa Oil Announces Completion of Farmin to Block 3B/4B in South Africa and Further Investment in Impact Oil & Gas

VANCOUVER, February 7, 2020 /CNW/ (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“AOI”, “Africa Oil” or “the Company”) is pleased to announce that the government of South Africa, has approved the acquisition of a 20% participating interest in the Block 3B/4B Exploration Right from Azinam Limited ("Azinam") by its wholly-owned subsidiary, Africa Oil SA Corp.. Africa Oil Corp. will assume operatorship for the joint venture partners; Azinam will retain a 20% participating interest and Ricocure (Pty) Ltd retains a 60% participating interest. Block 3B/4B (the “Block”) is located in the

Henrik Henriksson and Karin Overbeck proposed as new board members of AB Electrolux

In preparation for the Electrolux Annual General Meeting on March 31, 2020, the Electrolux Nomination Committee proposes the election of Henrik Henriksson and Karin Overbeck as new members of the Board of Directors of AB Electrolux. The committee also proposes re-election of Staffan Bohman (chairman), Petra Hedengran, Ulla Litzén, Fredrik Persson, David Porter, Jonas Samuelson and Kai Wärn as Board Members. Hasse Johansson and Ulrika Saxon have declined re-election.Henrik Henriksson is President and CEO of Scania AB. He is also a Board Member of Scania AB and Hexagon AB. He has previously

Invitation to conference call of Hoist Finance fourth quarter 2019 report

Hoist Finance will publish the interim report for the fourth quarter 2019 on Wednesday, February 12th, 2020, at approximately 07.30 AM (CET). A combined presentation and teleconference for investors, analysts and media will be held at 09.30 AM (CET). Klaus-Anders Nysteen, CEO and Christer Johansson, CFO will present and comment the report. The presentation will be held in English via a telephone conference or audio broadcast at:https://tv.streamfabriken.com/hoist-finance-q4-2019 No advance notification is necessary. Dial-in numbers for the conference call: SE: + 46850558353

Mekonomen Group strengthens the Group management team with Director of Business Development and Strategy

Following rapid growth through acquisitions in 2018 and subsequent consolidation, Mekonomen Group clarifies its focus on developing a long-term and competitive business. In order to intensify the strategic work, the Group management team is strengthened with Petra Bendelin as Director of Business Development and Strategy. In 2020, Mekonomen Group will continue its focus on purchasing synergies, efficiency and profitability in the core business. At the same time, the company clarifies its strategy towards a long-term competitive business. As part of intensifying the strategic work within

Interim Report January-December 2019

Improved profitability and strengthened cash flow“In 2019, we created a leading engineering and design company in the Nordics, and in the fourth quarter, we delivered improved profitability and strong cash flow”, said Jonas Gustavsson, President and CEO. Fourth quarter 2019 – Net sales amounted to SEK 5,447 million (3,957) – EBITA, excl. items affecting comparability, was SEK 516 million (357) – EBITA margin, excl. items affecting comparability, was 9.5 percent (9.0) – EBITA totalled SEK 327 million (332) – EBITA margin was 6.0 percent (8.4) – EBIT (operating profit)

Finnair Traffic Performance in January 2020